AstraZeneca and Roche Sign Mou To Improve Breast Cancer Diagnostics

AstraZeneca Pharma India Ltd and Roche Diagnostics India signed a memorandum of understanding (MoU) to improve diagnostics for breast cancer patients, with a particular emphasis on simplifying HER2 diagnostics with contemporary breakthroughs in...

SkylineDx and VIB Joins for Research Programme on Immune Prediction

SkylineDx has announced that Pointillism 2.0, a collaborative precision medicine project, has been selected for financing as part of the renowned VIB Grand Challenges Programme. This program intends to promote the advancement of socially relevant...

Medtronic and Cosmo Pharma Widen Ties To Deliver Continued Innovation

Medtronic plc, a global leader in healthcare technology announced the signing of a final agreement to expand its collaboration with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven collaboration will...

Zydus and Daewoong Pharma Sign Deal To Develop Leuprolide Acetate

Zydus Lifesciences Ltd signed a licensing agreement with Daewoong Pharmaceutical Co Ltd of South Korea on Monday to co-develop and commercialize a generic version of Leuprolide Acetate for depot suspension, which is used to treat advanced...

PNB VESPER and NIH-NIDA Ink Pact To Develop Drugs for Disorders

PNB VESPER, a Kochi-based research-based biopharmaceutical company, has signed agreements with the National Institute on Drug Abuse (NIDA), the lead federal agency supporting scientific research on drug abuse and addiction disorders, to develop...

Astellas Pharma Bags US FDA Nod For Cresemba To Treat Invasive Aspergillosis

As per Astellas Pharma US, Inc. Cresemba (isavuconazonium sulfate), an azole antifungal medication, has been approved by the US Food and medication Administration (FDA) for the treatment of invasive aspergillosis (IA) and invasive mucormycosis...

Sanofi and Minapharm Ink Pact To Manufacture Clexane

Sanofi and Minapharm have announced the signing of an exclusive Manufacturing and Supply Agreement for the localization of the entire Clexane product line. The agreement between Sanofi, a global pharmaceutical company and Egypt's Minapharm...

Babson Diagnostics Secures US FDA Nod For Blood Testing Service

Babson Diagnostics, a science-first health care technology business, announced that a key component of its BetterWay Blood Testing ecosystem has received FDA 510(k) clearance. These regulatory approvals open the way for Babson to launch BetterWay...

US FDA Nods Two Gene Therapies For Sickle Cell Disease

The U.S Food and Drug Administration (FDA) approved two gene therapies for sickle cell disease, including the first treatment in the country based on the Nobel Prize-winning CRISPR gene editing technique. Casgevy, developed by partners Vertex...

Revolutionizing Cancer Treatment: The Impact of Immunotherapy

Immunotherapy works on the principle that the ability of the body and the immune system to recognize and eliminate cancer cells. One of the most promising tools in this regard is immune response inhibitors.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.